Common medicines, including Paracetamol, may soon become costlier in India, with chemists in Visakhapatnam warning of a potential 30–40% increase in drug prices amid global supply disruptions linked to the ongoing Iran-related geopolitical tensions.
According to inputs from local pharmaceutical traders and chemist associations, rising costs of raw materials and disruptions in international supply chains are beginning to impact the pricing of essential medicines. The situation has been attributed to escalating tensions involving Iran, which is affecting the availability and transportation of key pharmaceutical ingredients.
Industry sources indicate that Active Pharmaceutical Ingredients (APIs), many of which are sourced globally, are witnessing price fluctuations due to increased freight costs, insurance premiums, and logistical uncertainties. These factors are contributing to a broader “pharma cost shock,” which is expected to reflect in retail medicine prices in the coming weeks.
Chemists in Visakhapatnam have cautioned that widely used over-the-counter drugs like paracetamol could be among the first to see price hikes, given their high demand and dependence on stable supply chains. The warning highlights concerns among retailers and distributors regarding stock availability and procurement costs.
The pharmaceutical supply chain is closely tied to global trade routes, and any disruption—particularly in energy corridors and shipping lanes—can have a cascading effect on manufacturing and distribution. Increased transportation costs and delays are already being reported by industry participants.
As of now, there has been no official notification from regulatory authorities regarding price revisions. However, stakeholders within the pharmaceutical sector have indicated that if current conditions persist, a price adjustment may become unavoidable.
The situation continues to be monitored by industry players, with further clarity expected based on developments in global markets and supply chain stability.